These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7942073)

  • 1. Evaluation of serum uric acid to creatinine ratio in fulminant hepatitis.
    Omori N; Ukida M; Mikami M; Morimoto Y; Tsuji T
    Acta Med Okayama; 1994 Jun; 48(3):159-64. PubMed ID: 7942073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma short-chain fatty acids in fulminant hepatic failure.
    Lai JC; Silk DB; Williams R
    Clin Chim Acta; 1977 Jul; 78(2):305-10. PubMed ID: 884861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indicators in fulminant hepatic failure.
    Frohburg E; Stölzel U; Lenz K; Schäfer JH; Tung LC; Riecken EO
    Z Gastroenterol; 1992 Sep; 30(9):571-5. PubMed ID: 1449004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
    Watanabe A; Takesue A; Higashi T; Nagashima N
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum creatinine levels in severe hepatic disease.
    Takabatake T; Ohta H; Ishida Y; Hara H; Ushiogi Y; Hattori N
    Arch Intern Med; 1988 Jun; 148(6):1313-5. PubMed ID: 3377614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic assessment of fulminant hepatitis from indication criteria for liver transplantation.
    Watanabe A; Shiota T; Tsuji T
    J Med; 1992; 23(1):39-49. PubMed ID: 1374114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of kidney function in hepatic coma].
    Lochs H; Kleinberger G; Druml W
    Leber Magen Darm; 1982 Oct; 12(5):203-7. PubMed ID: 7182701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum uric acid level in type 1 and type 2 diabetic patients].
    Zazgornik J; Biesenbach G; Janko O; Grafinger P; Kaiser W; Stuby U; Hubmann R
    Wien Med Wochenschr; 1996; 146(5):102-4. PubMed ID: 8686325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers.
    Alasia DD; Emem-Chioma PC; Wokoma FS
    Int J Occup Environ Med; 2010 Oct; 1(4):182-90. PubMed ID: 23022807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine uric acid and urine creatine ratio in acute renal failure.
    Tungsanga K; Boonwichit D; Lekhakula A; Sitprija V
    Arch Intern Med; 1984 May; 144(5):934-7. PubMed ID: 6712409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine on serum uric acid concentration.
    Berardi RR; Hyneck ML; Cohen IA; Cornish LA; Achem SR
    Clin Pharm; 1984; 3(1):56-9. PubMed ID: 6697675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of renal hypouricemia associated with IgA nephropathy--with special reference to changes in serum uric acid and uric acid clearance in a clinical course exceeding 15 years].
    Tofuku Y; Nakashima A; Koni I
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):277-83. PubMed ID: 8196225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.
    Horak W; Waldram R; Murray-Lyon IM; Schuster E; Williams R
    Gastroenterology; 1976 Nov; 71(5):809-13. PubMed ID: 964572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of alpha-foetoprotein in fulminant hepatitis (author's transl)].
    Pastore G; Lapedota E; Dentico P; Buongiorno R; Mallardi M; Angarano G; Schiraldi O
    Quad Sclavo Diagn; 1979 Mar; 15(1):14-21. PubMed ID: 94446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
    Rosen HM; Yoshimura N; Hodgman JM; Fischer JE
    Gastroenterology; 1977 Mar; 72(3):483-7. PubMed ID: 832796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of combined plasma exchange treatment in fulminant viral hepatitis].
    Markus R; Baumgarten R; Fengler JD; Bartke D; Binus R; Fischer J; Kilger B; Miersch H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):197-204. PubMed ID: 4085389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.